B Cell News and Research

RSS

New ERC-funded research project aims to develop targeted treatments for chronic wounds and cancer

the Freiburg University Medical Center and member of the Medical Faculty at the University of Freiburg, has received a European Research Council (ERC) Starting Grant from the European Commission.

27 Oct 2023

AI-nanopore platform can detect SARS-CoV-2 variants with high accuracy

A rapid, accurate way of testing for COVID-19 infection would be a big step in overcoming the virus' hold over our society.

27 Oct 2023

Common chemical label shields proteins from degradation

Researchers from the University of Bergen (UiB) have uncovered that proteins use a common chemical label as a shield to protect them from degradation, which in turn affects motility and aging.

27 Oct 2023

Novel replacement strategy holds promise for the treatment of various genetic disorders

Severe Combined Immunodeficiencies (SCIDs) are a group of debilitating primary immunodeficiency disorders, primarily caused by genetic mutations that disrupt T-cell development. SCID can also affect B-cell and natural killer cell function and counts.

27 Oct 2023

Single-cell proteomics – when mass spectrometry revolutionizes biomedical research

In the latest episode of the OMG Omx podcast, Bruker's Kate Stumpo talks to Nikolai Slavov about the incredible potential of mass spectrometry proteomics in biomedical research.

From Bruker Daltonics 27 Oct 2023

Beckman Coulter Life Sciences and 10x Genomics partner to enable single cell workflow automation

Beckman Coulter Life Sciences and 10x Genomics, Inc. today announced a new partnership to expand automation solutions for single cell assay workflows.

From Beckman Coulter Life Sciences 27 Oct 2023

Microbubble-based biomarker could improve NIR-PIT treatment for cancer

Researchers at Nagoya University in Japan and their collaborators have used a biomarker based on microbubbles to evaluate the success of near-infrared photoimmunotherapy (NIR-PIT) treatment.

26 Oct 2023

Malaria protein discovery opens new avenues for combating deadly infection

The discovery of a malaria protein that helps the parasite grow inside red blood cells and plays a key regulatory role in the parasite's immune evasion tactics could pave the way for new vaccines or therapeutics to combat the deadly infection.

26 Oct 2023

City of Hope, TGen receive $4.5 million to validate liquid biopsy for early detection of pancreatic cancer

City of Hope, one of the largest cancer research and treatment organizations in the United States, and TGen are leading an international group that has been awarded $4.5 million to validate a liquid biopsy for the early detection of pancreatic cancer.

26 Oct 2023

Dato-DXd improves progression-free survival in patients with metastatic non-squamous NSCLC

Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients with metastatic non-small cell lung cancer, an improvement that was primarily driven by patients with non-squamous tumors.

26 Oct 2023

New study challenges long-held belief about how chemotherapy works

A new study from the University of Wisconsin–Madison suggests that chemotherapy may not be reaching its full potential, in part because researchers and doctors have long misunderstood how some of the most common cancer drugs actually ward off tumors.

26 Oct 2023

Groundbreaking research advances understanding of how pathogens impact cancer

Viral infections are known to be a central cause of more than 10% of cancers worldwide. University of California researchers may have uncovered one of the key reasons why.

26 Oct 2023

Endometriosis and irritable bowel syndrome share genetic risk factors, UQ research shows

University of Queensland researchers have shown that endometriosis and irritable bowel syndrome (IBS) share genetic risk factors, explaining why patients with one condition may also have the other.

26 Oct 2023

New nanoparticle-based system developed for comprehensive treatment of rheumatoid arthritis

A team of scientists led by KOO Sagang from the Seoul National University and Center for Nanoparticle Research within the Institue for Basic Science Center (IBS), in collaboration with researchers from Korea Institute of Science and Technology (KIST) and the Seoul National University, developed a new solution for the treatment of rheumatoid arthritis (RA).

26 Oct 2023

B Cell News and Research

New ERC-funded research project aims to develop targeted treatments for chronic wounds and cancer

AI-nanopore platform can detect SARS-CoV-2 variants with high accuracy

Common chemical label shields proteins from degradation

Novel replacement strategy holds promise for the treatment of various genetic disorders

Single-cell proteomics – when mass spectrometry revolutionizes biomedical research

Beckman Coulter Life Sciences and 10x Genomics partner to enable single cell workflow automation

Microbubble-based biomarker could improve NIR-PIT treatment for cancer

Malaria protein discovery opens new avenues for combating deadly infection

City of Hope, TGen receive $4.5 million to validate liquid biopsy for early detection of pancreatic cancer

Dato-DXd improves progression-free survival in patients with metastatic non-squamous NSCLC

New study challenges long-held belief about how chemotherapy works

Groundbreaking research advances understanding of how pathogens impact cancer

Endometriosis and irritable bowel syndrome share genetic risk factors, UQ research shows

New nanoparticle-based system developed for comprehensive treatment of rheumatoid arthritis

Somatic mutations in the skin not responsible for the start or spread of psoriasis

Newly identified amino acid may play key role in predicting outcomes and treatment of long COVID

Immunologists aim to explore new avenues for immunotherapy of liver metastases

New bioreactor could accelerate access to cancer-killing immunotherapy

Discovery of protein interaction could lead to new schizophrenia treatments

New AI-nanopore platform could revolutionize COVID-19 testing

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News